{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:44:10Z","timestamp":1789494250027,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":19,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011703","name":"Yorkshire Cancer Research","doi-asserted-by":"publisher","award":["L389LM"],"award-info":[{"award-number":["L389LM"]}],"id":[{"id":"10.13039\/100011703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.phro.2023.100476","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T04:42:44Z","timestamp":1690260164000},"page":"100476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["The role and potential of using quantitative MRI biomarkers for imaging guidance in brain cancer radiotherapy treatment planning: A systematic review"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0355-8232","authenticated-orcid":false,"given":"Abeer M.","family":"Aldawsari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashar","family":"Al-Qaisieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-4762","authenticated-orcid":false,"given":"David A.","family":"Broadbent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8981-1640","authenticated-orcid":false,"given":"Richard","family":"Speight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2023.100476_b0005","unstructured":"Cancer Research UK. Brain, other CNS and intracranial tumours statistics, https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/brain-other-cns-and-intracranial-tumours; 2019 [Accessed 23 February 2022]."},{"key":"10.1016\/j.phro.2023.100476_b0010","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.phro.2023.100476_b0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/0360-3016(92)90727-Y","article-title":"The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms","volume":"24","author":"Thornton","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00234-017-1955-3","article-title":"Differentiation of residual\/recurrent gliomas from postradiation necrosis with arterial spin labeling and diffusion tensor magnetic resonance imaging-derived metrics","volume":"60","author":"Razek","year":"2018","journal-title":"Neuroradiology"},{"key":"10.1016\/j.phro.2023.100476_b0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejmp.2019.03.014","article-title":"Imaging biomarker analysis of advanced multiparametric MRI for glioma grading","volume":"60","author":"Vamvakas","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2023.100476_b0030","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S1460396917000693","article-title":"Magnetic resonance imaging in radiotherapy treatment target volumes definition for brain tumours: A systematic review and meta-analysis","volume":"17","author":"Abubakar","year":"2018","journal-title":"J Radiother Pract"},{"key":"10.1016\/j.phro.2023.100476_b0035","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1148\/radiol.2472070898","article-title":"Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging","volume":"247","author":"Law","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.phro.2023.100476_b0040","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.canrad.2020.03.005","article-title":"Anatomical and functional MR imaging to define tumoral boundaries and characterize lesions in neuro-oncology","volume":"24","author":"Benzakoun","year":"2020","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.phro.2023.100476_b0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13244-020-00888-1","article-title":"Multiparametric MRI: practical approach and pictorial review of a useful tool in the evaluation of brain tumours and tumour-like lesions","volume":"11","author":"Sawlani","year":"2020","journal-title":"Insights Imaging"},{"key":"10.1016\/j.phro.2023.100476_b0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0720-048X(02)00303-0","article-title":"Basic principles of diffusion-weighted imaging","volume":"45","author":"Bammer","year":"2003","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.phro.2023.100476_b0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0006-3495(94)80775-1","article-title":"MR diffusion tensor spectroscopy and imaging","volume":"66","author":"Basser","year":"1994","journal-title":"Biophys J"},{"key":"10.1016\/j.phro.2023.100476_b0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nurt.2007.05.011","article-title":"Diffusion tensor imaging of the brain","volume":"4","author":"Alexander","year":"2007","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.phro.2023.100476_b0065","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O","article-title":"In vivo fiber tractography using DT-MRI data","volume":"44","author":"Basser","year":"2000","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.phro.2023.100476_b0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.nic.2009.08.007","article-title":"Magnetic resonance perfusion and permeability imaging in brain tumors","volume":"19","author":"Lacerda","year":"2009","journal-title":"Neuroimaging Clin N Am"},{"key":"10.1016\/j.phro.2023.100476_b0075","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2214\/AJR.12.9543","article-title":"Perfusion MRI: the five most frequently asked technical questions","volume":"200","author":"Essig","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.phro.2023.100476_b0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiology.191.1.8134596","article-title":"Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings","volume":"191","author":"Aronen","year":"1994","journal-title":"Radiology"},{"key":"10.1016\/j.phro.2023.100476_b0085","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1200\/JCO.2005.04.7233","article-title":"Physiologic and metabolic magnetic resonance imaging in gliomas","volume":"24","author":"Cao","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiology.187.1.8451417","article-title":"Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra","volume":"187","author":"Michaelis","year":"1993","journal-title":"Radiology"},{"issue":"133\u20139","key":"10.1016\/j.phro.2023.100476_b0095","first-page":"vii","article-title":"Overview of functional magnetic resonance imaging","volume":"22","author":"Glover","year":"2011","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.phro.2023.100476_b0100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging\u2014\u201chow-to\u201d guide and critical reflection","volume":"11","author":"van Timmeren","year":"2020","journal-title":"Insights Imaging"},{"key":"10.1016\/j.phro.2023.100476_b0105","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.wneu.2019.06.027","article-title":"Utilisation of diffusion tensor imaging in intracranial radiotherapy and radiosurgery planning for white matter dose optimization: a systematic review","volume":"130","author":"Yahya","year":"2019","journal-title":"World Neurosurg"},{"key":"10.1016\/j.phro.2023.100476_b0110","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.phro.2023.100476_b0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.phro.2023.100476_b0120","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.3346\/jkms.2015.30.10.1522","article-title":"Dosimetric effects of magnetic resonance imaging-assisted radiotherapy planning: dose optimization for target volumes at high risk and analytic radiobiological dose evaluation","volume":"30","author":"Park","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.phro.2023.100476_b0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s11060-016-2320-9","article-title":"Use of diffusion-weighted MRI to modify radiosurgery planning in brain metastases may reduce local recurrence","volume":"131","author":"Zakaria","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.phro.2023.100476_b0130","doi-asserted-by":"crossref","first-page":"118","DOI":"10.18383\/j.tom.2018.00035","article-title":"Developing a pipeline for multiparametric MRI-guided radiation therapy: initial results from a phase II clinical trial in newly diagnosed glioblastoma","volume":"5","author":"Kim","year":"2019","journal-title":"Tomography"},{"key":"10.1016\/j.phro.2023.100476_b0135","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2021.01.033","article-title":"A phase 2 study of dose-intensified chemoradiation using biologically based target volume definition in patients with newly diagnosed glioblastoma","volume":"110","author":"Kim","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.phro.2022.06.004","article-title":"Repeatability of radiotherapy dose-painting prescriptions derived from a multiparametric magnetic resonance imaging model of glioblastoma infiltration","volume":"23","author":"Brighi","year":"2022","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.clon.2005.04.012","article-title":"Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high-grade glioma","volume":"17","author":"Jena","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.phro.2023.100476_b0150","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00066-014-0676-3","article-title":"Diffusion tensor imaging for target volume definition in glioblastoma multiforme","volume":"190","author":"Berberat","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.phro.2023.100476_b0155","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.rpor.2014.01.002","article-title":"Corticospinal tract-sparing intensity-modulated radiotherapy treatment planning","volume":"19","author":"Igaki","year":"2014","journal-title":"Rep Pract Oncol Radiother"},{"key":"10.1016\/j.phro.2023.100476_b0160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13014-015-0364-1","article-title":"Integration of BOLD-fMRI and DTI into radiation treatment planning for high-grade gliomas located near the primary motor cortexes and corticospinal tracts","volume":"10","author":"Wang","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0165","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1080\/0284186X.2017.1374559","article-title":"Diffusion tensor magnetic resonance imaging driven growth modeling for radiotherapy target definition in glioblastoma","volume":"56","author":"Jensen","year":"2017","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0170","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejmp.2018.10.004","article-title":"Integration of Diffusion Magnetic Resonance Tractography into tomotherapy radiation treatment planning for high-grade gliomas","volume":"55","author":"Altabella","year":"2018","journal-title":"Phys Med"},{"key":"10.1016\/j.phro.2023.100476_b0175","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.radonc.2022.04.012","article-title":"nTMS-derived DTI-based motor fiber tracking in radiotherapy treatment planning of high-grade gliomas for avoidance of motor structures","volume":"171","author":"Diehl","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijrobp.2003.08.023","article-title":"3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI","volume":"59","author":"Pirzkall","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ijrobp.2007.03.019","article-title":"Patterns of recurrence analysis in newly diagnosed glioblastoma multiforme after three-dimensional conformal radiation therapy with respect to pre-radiation therapy magnetic resonance spectroscopic findings","volume":"69","author":"Park","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-1","article-title":"Integration method of 3D MR spectroscopy into treatment planning system for glioblastoma IMRT dose painting with integrated simultaneous boost","volume":"8","author":"Ken","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0195","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.ijrobp.2014.03.049","article-title":"Volumetric spectroscopic imaging of glioblastoma multiforme radiation treatment volumes","volume":"90","author":"Parra","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0200","doi-asserted-by":"crossref","first-page":"366","DOI":"10.18383\/j.tom.2016.00187","article-title":"Simulating the effect of spectroscopic MRI as a metric for radiation therapy planning in patients with glioblastoma","volume":"2","author":"Cordova","year":"2016","journal-title":"Tomography"},{"key":"10.1016\/j.phro.2023.100476_b0205","first-page":"1569","article-title":"Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients","volume":"18","author":"Jafari","year":"2016","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0210","doi-asserted-by":"crossref","first-page":"184","DOI":"10.18383\/j.tom.2018.00028","article-title":"The brain imaging collaboration suite (Br ICS): a cloud platform for integrating whole-brain spectroscopic MRI into the radiation therapy planning workflow","volume":"5","author":"Gurbani","year":"2019","journal-title":"Tomography"},{"key":"10.1016\/j.phro.2023.100476_b0215","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1158\/1078-0432.CCR-10-2098","article-title":"Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment","volume":"17","author":"Galb\u00e1n","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.phro.2023.100476_b0220","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0009-9260(03)00115-6","article-title":"Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion?","volume":"58","author":"Price","year":"2003","journal-title":"Clin Radiol"},{"key":"10.1016\/j.phro.2023.100476_b0225","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3171\/jns.2005.102.4.0664","article-title":"Combined use of tractography-integrated functional neuronavigation and direct fiber stimulation","volume":"102","author":"Kamada","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1016\/j.phro.2023.100476_b0230","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/mrm.20625","article-title":"Simulation of anisotropic growth of low-grade gliomas using diffusion tensor imaging","volume":"54","author":"Jbabdi","year":"2005","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.phro.2023.100476_b0235","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11604-007-0209-4","article-title":"Serial diffusion tensor imaging to characterize radiation-induced changes in normal-appearing white matter following radiotherapy in patients with adult low-grade gliomas","volume":"26","author":"Haris","year":"2008","journal-title":"Radiat Med"},{"key":"10.1016\/j.phro.2023.100476_b0240","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2015.12.003","article-title":"ESTRO-ACROP guideline \u201ctarget delineation of glioblastomas\u201d","volume":"118","author":"Niyazi","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2023.100476_b0245","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/jmri.20683","article-title":"Artifacts and pitfalls in diffusion MRI","volume":"24","author":"Le Bihan","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.phro.2023.100476_b0250","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/mrm.22024","article-title":"High resolution diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging and a two-dimensional navigator-based reacquisition","volume":"62","author":"Porter","year":"2009","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.phro.2023.100476_b0255","article-title":"IPEM topical report: guidance on the use of MRI for external beam radiotherapy treatment planning","volume":"66","author":"Speight","year":"2021","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2023.100476_b0260","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(02)02869-9","article-title":"Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy","volume":"53","author":"Pirzkall","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0265","first-page":"604","article-title":"Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens","volume":"22","author":"Dowling","year":"2001","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.phro.2023.100476_b0270","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0360-3016(01)01548-6","article-title":"MR-spectroscopy guided target delineation for high-grade gliomas","volume":"50","author":"Pirzkall","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0275","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.ijrobp.2007.10.039","article-title":"Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study","volume":"70","author":"Laprie","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2023.100476_b0280","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/mrm.10367","article-title":"Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy","volume":"49","author":"Howe","year":"2003","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.phro.2023.100476_b0285","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00004728-199007000-00001","article-title":"Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies","volume":"14","author":"Gill","year":"1990","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.phro.2023.100476_b0290","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12885-019-5317-x","article-title":"Dose-painting multicenter phase III trial in newly diagnosed glioblastoma: the SPECTRO-GLIO trial comparing arm A standard radiochemotherapy to arm B radiochemotherapy with simultaneous integrated boost guided by MR spectroscopic imaging","volume":"19","author":"Laprie","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phro.2023.100476_b0295","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-011-0737-8","article-title":"Non-invasive detection of 2-hydroxyglutarate and other metabolites in IDH1 mutant glioma patients using magnetic resonance spectroscopy","volume":"107","author":"Pope","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.phro.2023.100476_b0300","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/(SICI)1522-2594(200001)43:1<23::AID-MRM4>3.0.CO;2-E","article-title":"Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer","volume":"43","author":"Tran","year":"2000","journal-title":"Magn Reson Med"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631623000672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631623000672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:17:29Z","timestamp":1762503449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631623000672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":60,"alternative-id":["S2405631623000672"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2023.100476","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role and potential of using quantitative MRI biomarkers for imaging guidance in brain cancer radiotherapy treatment planning: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2023.100476","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100476"}}